Jayne Smith‐Palmer

Statistics

Publications

Citations

621

H-Index

Active since

2008

Affiliations

Medtronic (Switzerland)(Current)

Federal Department of Finance

Dexcom (United States)

Novo Nordisk (Switzerland)

Örebro University

Jayne Smith‐Palmer is an author at Medtronic (Switzerland) specializing in cost-effectiveness analysis, pharmacoeconomic modeling, and pharmacoeconomics.

ORCID

Publications per year

2008–2023

Publications

<p>Impact of Stigma on People Living with Chronic Hepatitis B</p>

Jayne Smith‐Palmer, Karin Cerri, U. Sbarigia et al. · Patient Related Outcome Measures · 2020 · 94 citations · Full text

Social Sciences, Health Sciences, Behavioral Health +14

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Rémi Marty, Stéphane Roze, Xavier Bresse et al. · BMC Cancer · 2013 · 77 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

Johan Jendle, Johannes Pöhlmann, Simona de Portu et al. · Diabetes Technology & Therapeutics · 2019 · 52 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.

Stéphane Roze, John J. Isitt, Jayne Smith‐Palmer et al. · Diabetes Care · 2020 · 43 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective

Stéphane Roze, Jayne Smith‐Palmer, William J. Valentine et al. · Journal of Medical Economics · 2015 · 41 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17

1–5 of 22